Kinnate Biopharma Investor Relations Material

Kinnate Biopharma Inc. is a clinical-stage biotechnology company focused on the field of precision oncology. The company's mission is to develop targeted therapies for patients with cancer, particularly those with genetic mutations and fusions that are not currently addressed by existing treatments. Kinnate Biopharma specializes in the design and development of selective small molecules that target these genetic anomalies, aiming to provide novel treatment options for patients battling various forms of cancer. The company is headquartered in San Francisco, California, and its shares are listed on the Nasdaq.